Skip to content
Clinical Trials – home

Samodzielny Publiczny Wojewodzki Szpital Zespolony W Szczecinie

Verified siteinfo

Poland Ul. Arkonska 4, 71-455 Szczecin, Poland

  • 2 trials recruiting
  • HIV infection · COVID-19 · Cough
  • Adult patients

About Specializations

Samodzielny Publiczny Wojewodzki Szpital Zespolony W Szczecinie in Szczecin, Poland specialises in clinical trials of conditions such as HIV infection, COVID-19, Cough, Idiopathic pulmonary fibrosis, and other specialisations. This site conducts important research.

Main research areas of the site

Viral Diseases and HIV Research

At Samodzielny Publiczny Wojewodzki Szpital Zespolony W Szczecinie, clinical trials in virus diseases focus mainly on HIV-1 infection and broader HIV infections. These studies are exploring new treatment options, including oral regimens and switching strategies, to better control the virus and support long-term care.

  • Evaluating new antiviral approaches for people living with HIV-1
  • Comparing emerging oral therapies with current standard treatment for HIV
  • Studying treatment options for both treatment-naive and virologically suppressed participants

This research aims to improve convenience, effectiveness, and overall management of chronic HIV care.

Respiratory Tract Diseases Research

The site also supports trials in respiratory tract diseases, with work centered on COVID-19 and idiopathic pulmonary fibrosis. These studies are designed to test new therapies and assess whether they can improve recovery, breathing function, and outcomes for patients with serious lung conditions.

  • Testing immune-based treatment strategies for hospitalized patients with COVID-19
  • Evaluating therapies aimed at improving lung function in idiopathic pulmonary fibrosis
  • Studying treatment effectiveness in acute and chronic respiratory illness

This area reflects an emphasis on both urgent infection-related care and longer-term lung disease management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Arkonska 471-455 SzczecinPoland
Recruiting now
2 trials
Conditions studied
4
Partner status
Verified site

More sites in SzczecinPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

10 clinical trials

HIV infection

Recruiting

Switching to lenacapavir-based drug combination vs cabotegravir-based drug combination in virologically suppressed adults with HIV-1

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cabotegravir
  • Sponsor:Gilead Sciences Inc.

HIV infection

Recruiting

A study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dolutegravir Sodium
  • Sponsor:Viiv Healthcare UK Limited

Cough

Not yet recruiting

A Randomized Dose‑Ranging Study of Nalbuphine Hydrochloride Extended‑Release Tablets in Adults with Refractory Chronic Cough

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nalbuphine Hydrochloride
  • Sponsor:Trevi Therapeutics Inc.

HIV infection

Not yet recruiting

Safety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Gilead Sciences Inc.

A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zampilimab
  • Sponsor:Chiesi Farmaceutici S.p.A.

HIV infection

Not yet recruiting

Study of Weekly Oral GS-1720 and GS-4182 for People with HIV-1 Who Are Virologically Suppressed

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Gilead Sciences Inc.

HIV infection

Not recruiting

Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Gilead Sciences Inc.

HIV infection

Not recruiting

Study Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abacavir
  • Sponsor:Gilead Sciences Inc.

COVID-19

Not recruiting

Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:University Of Minnesota

HIV infection

Not recruiting

Study on the Effects of GSK3739937 for Adults with HIV-1 Who Have Not Yet Received Treatment

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:GSK3739937
  • Sponsor:Viiv Healthcare UK Limited
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.